Immune Mechanism of Foot and Mouth Disease and Treatment of
Allergic Reaction to Vaccine
Yanxi Qiu
Malvern College Chengdu, Chengdu, Sichuan, China
Keywords:
Foot-and-Mouth Disease, Immune Mechanism, Vaccine Allergic Reactions, Rescue Measures.
Abstract: Allergic reactions caused by FMD vaccine are often encountered in the process of FMD immunization. If
not treated in time, it can cause the death of immunized animals and economic losses. This paper mainly
introduces the immune mechanism of FMD, the mechanism of allergic reaction of vaccine, the clinical
symptoms and treatment measures of allergic reaction of FMD vaccine and preventive measures, aim to
provide reference for better avoiding the occurrence of allergic reaction of FMD vaccine.
1 INTRODUCTION
Foot-and-mouth disease (FMD) is an acute, febrile,
highly contagious zoonosis caused by Foot-and-
mouth disease virus (FMDV). The genome of
FMDV is a single-stranded positive-sense RNA
with a total length of approximately 8,500
nucleotides. There are seven serotypes of FMDV,
namely O, A, C, SAT I, SAT II, SAT III and Asia I.
More than 80 subtypes, each serotype has different
antigenicity and there is no cross-immune protection
between the serotypes. Foot-and-mouth disease
(FMD) has caused significant economic losses to
animal husbandry and is the focus of quarantine and
epidemic prevention in various countries around the
world. Vaccines, available since the early 1900s,
have been the most instrumental method for
prevention and control of FMD. However, the
allergic reactions caused by vaccines should not be
ignored, which may even cause animal death.
2 IMMUNE MECHANISM OF
FOOT-AND-MOUTH DISEASE
2.1 Humoral Immunity
The immune response mediated by B cells is called
humoral immunity, and humoral immune effect is
achieved by B cells through the recognition of
antigens, activation, proliferation and finally
differentiation into plasma cells and secretion of
antibodies. Therefore, antibodies are immune
molecules that mediate humoral immune effect.
Antibodies are immune globulins secreted by B
lymphocytes after activation and have important
anti-infective effects. According to the differences
in chemical structure and antigenicity, the antibodies
of animals can be divided into five categories,
namely IgM, IgG, IgA, IgE and IgD, of which, IgG
and IgA have different subclasses. IgM is the largest
immunoglobulin molecule and consists of a
pentamer of five monomers of the same size as IgG.
IgM is the earliest antibody produced by the animal
body after the initial antigenic stimulation. Among
them, the effect of neutralizing the virus is weak, but
the ability to bind complement is strong. IgG is the
most important antibody and the most important
immunoglobulin in serum, accounting for about
75% of the total immunoglobulin, and is widely
distributed in the body. Among all
immunoglobulins, IgG has the strongest virus
neutralization and can exert immune activities such
as antibacterial, antiviral, and neutralizing viruses.
IgA is present in mucosal secretions and other
secretions, and IgA is also present in the blood, and
IgA is associated with local immunity. The site of
IgE production, similar to IgA, is produced by
plasma cells in the lamina propria of the respiratory
and digestive tracts and is present in little amount in
the serum. IgE is a cytophilic antibody that readily
binds to eosinophils and vascular endothelial cells in
skin tissue, mast cells, blood and can mediate type I
allergic reactions. IgE also has an important role in
Qiu, Y.
Immune Mechanism of Foot and Mouth Disease and Treatment of Allergic Reaction to Vaccine.
DOI: 10.5220/0012000400003625
In Proceedings of the 1st International Conference on Food Science and Biotechnology (FSB 2022), pages 5-7
ISBN: 978-989-758-638-5
Copyright
c
2023 by SCITEPRESS Science and Technology Publications, Lda. Under CC license (CC BY-NC-ND 4.0)
5
anti-parasitic, certain fungal infections. The
secretion of IgD is rare, and its content in serum is
very low, and unstable, and easily degraded. Some
researchers believe that IgD is related to immune
memory, and some reports suggest that IgD is
related to some allergic reactions.
After animals are exposed to FMDV antigen, a
specific immune response dominated by humoral
immunity is induced and neutralizing antibodies are
produced, which mainly destroy FMDV with
neutralizing and opsonizing effects.
2.2 Cellular Immunity
The function of anti-FMD infection is mainly
related to humoral immunity, but the role of cellular
immunity and cytokines produced by immune cells
in the immune response to FMD cannot be ignored.
At present, the role and mechanism of cellular
immunity in FMD immunity are not fully
understood, and some progress has been made using
synthetic peptides and T cell technology
(
Alexandersen, 2005)
. Synthetic peptides
containing only B cell epitopes have low
immunogenicity, which may be related to MHC
(major histocompatibility complex) restriction, and
the introduction of Th cell (helper T cell) epitopes
can overcome the limitations and induce the
production of high levels of protective antibodies.
Both natural host pigs and cattle have FMDV
serotype-cross-reactive T cells, and this T cell
epitope is present on structural proteins VP1 and
VP3 (Arztl, 2011). After immunization of pigs with
FMDV inactivated antigen, the number of CD4
+
and
Th cells increased significantly, and lymphocytes
with immune memory could be present in the
circulatory system for at least 1 year (Ayebazibwe,
2010). In vitro, each structural protein of FMDV can
stimulate the proliferation of this cell, of which VP1
and VP3 proteins are more effective, and the
proliferative response is dependent on the antigen
dose. This shows that Th cells are involved in the
immune response to FMDV inactivated antigens.
2.3 Local Immunity
Local immunity is an extension of humoral
immunity and is mainly characterized by the
production of secretory IgA. Pharyngeal mucosal
immunity in FMD is of interest because this site is
the site of initial infection with FMDV and long-
term virus carriage.
3 MECHANISM OF ALLERGIC
REACTION TO VACCINE
Allergic reactions caused by foot-and-mouth disease
vaccine are type I allergic reactions. This reaction is
a complex process: the allergen enters the animal
body for the first time, stimulates the animal body to
produce a large amount of allergic antibody IgE, IgE
adsorbs on the mast cells of tissues and the basophil
surface of blood, so that the animal body is in a
sensitized state. When the sensitized body is re-
exposed to the same allergen, the allergic principle
binds to the IgE antibody attached to the surface of
mast cells and basophils, activates the intracellular
enzyme system, resulting in the rapid release of
various bioactive substances by cellular endocrine
granules. For example, histamine, serotonin and
anaphylatoxin, these bioactive substances can cause
inflammatory reactions, resulting in a series of
allergic reaction symptoms such as telangiectasia
and increased permeability, mucocutaneous edema,
decreased blood pressure and respiratory smooth
muscle spasm.
4 CLINICAL SYMPTOMS AND
TREATMENT OF ALLERGIC
REACTION TO
FOOT-AND-MOUTH DISEASE
VACCINE
4.1 Mild Allergic Reactions
It is a normal vaccine response and its clinical
symptoms are not obvious. Only a few pigs in the
vaccinated herd showed mild apathy and loss of
appetite (Belsham, 2011). In general, it does not
require treatment and resolves spontaneously in 1 to
2 days.
4.2 Moderate Allergic Reactions
It often occurs in groups and appears about 15
minutes after injection of the vaccine. The clinical
symptoms were very pronounced and manifested as
dyspnea, salivation, vomiting, generalized cyanosis,
unsteady standing, and intoxicated gait. Allergic
pigs are generally weak and bedridden. A small
number of pigs were also seen standing with limbs
open and sunk back (Doel, 2003). After the
occurrence of the above symptoms, epinephrine
hydrochloride or glucocorticoids should be used as
FSB 2022 - The International Conference on Food Science and Biotechnology
6
soon as possible for treatment, while paying
attention to keeping the environment quiet and
providing adequate drinking water.
4.3 Severe Acute Allergic Reactions
It is rare, often occurring within 15 minutes after
injection of the vaccine, and severe allergic
symptoms occur a few seconds after injection of the
vaccine. The main symptoms are: allergic animals
suddenly fall to the ground, general weakness;
dyspnea, salivation, pale conjunctiva, systemic
cyanosis, decreased body temperature; systemic
muscle tremor, confusion, ataxia, incontinence,
unresponsiveness to various stimuli; severe cases
may develop anaphylactic shock, which can cause
death if not timely rescued (Ecuru, 2010).
For severe acute allergic reactions, epinephrine
injection should be performed immediately for
treatment, and some adjuvant therapy can be taken if
necessary.
5 PREVENTIVE MEASURES
Establish a reasonable immunization schedule to
avoid simultaneous immunization with other
vaccines and minimize the occurrence of stress
reactions to foot-and-mouth disease vaccines.
Before immunization, disinfection and sterilization
of devices should be done well, and drugs such as
epinephrine or glucocorticoids should be prepared at
the same time in order to treat allergic pigs timely.
During the immunization, operate in accordance
with the specifications strictly, inject according to
the dose specified in the instructions, and postpone
the immunization for the thin, pregnant animals with
a history of allergy. After the completion of vaccine
injection, attention should be paid to observation. If
allergic reactions occurred, contact the professionals
to take treatment measures as soon as possible. In
addition, establish immunization archives timely. In
case of any death of animals due to allergic reaction,
relevant personnel shall be contacted for harmless
treatment immediately.
6 CONCLUSION
The globalization of commerce is accelerating the
spread of FMDV and presents new requirements on
the trade of animals and animal productions. But
novel vaccines against FMDV are developed slowly,
and only few available novel FMD vaccines have
been used in practice. In the development of new
vaccines, we should improve the effectiveness while
give attention to safety, minimize allergic reactions
and reduce the physical discomfort and death of
animals caused by vaccination.
REFERENCES
Alexandersen, S., Mowat, N., 2005. Foot-and-mouth
disease: host range and pathogenesis, Current Topics
in Microbiology and Immunology, 288, 9–42.
Arztl, J., Juleff, N., Zhang, Z. and Rodriguez, L. L., 2011.
The pathogenesis of Foot-and-mouth disease I: viral
pathways in cattle, Transboundary and Emerging
Diseases. 58, 291–304.
Ayebazibwe, C., Tjørnehøj, K., Mwiine, F. N.,
Muwanika, V. B., Ademun, O. A. R., Siegismund, H.
R., Alexandersen, S., 2010a. Patterns, risk factors and
characteristics of reported and perceived foot-and-
mouth disease (FMD) in Uganda, Tropical Animal
Health and Production, 42(7), 1547–1559.
Belsham, J. G., Jamal, S. M., Tjørnehøj, K., Bøtner, A.,
2011. Rescue of Foot-and-Mouth Disease Viruses that
are Pathogenic for Cattle from Preserved Viral RNA
Samples. PLoS ONE, 6(1), e14621.
Doel, T. R., 2003. FMD Vaccines, Virus Research, 91,
81–99.
Ecuru, J. and Naluyima, H., 2010. Biotechnology
developments in Uganda and associated challenges,
African Crop Science Journal, 18 (4), 133–139.
Immune Mechanism of Foot and Mouth Disease and Treatment of Allergic Reaction to Vaccine
7